|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.660 HKD | -0.54% |
|
+1.67% | -13.68% |
| Nov. 20 | Hangzhou Jiuyuan Gene Engineering Launches Up to HK$570 Million Hong Kong IPO | MT |
| Nov. 15 | FX, China Industrial Outlook Churn Asian Stock Markets | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions on site
| Capitalization | 55.4B 59.18B 7.6B 7.23B 6.74B 6.01B 10.7B 644B 11.74B 83.77B 31.06B 264B 28.57B 27.93B 1,137B | P/E ratio 2025 * |
32.3x | P/E ratio 2026 * | 25.7x |
|---|---|---|---|---|---|
| Enterprise value | 43.67B 46.66B 5.99B 5.7B 5.31B 4.73B 8.43B 508B 9.26B 66.05B 24.49B 208B 22.52B 22.02B 896B | EV / Sales 2025 * |
1.42x | EV / Sales 2026 * | 1.23x |
| Free-Float |
36.15% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
More recommendations
More press releases
More news
| 1 day | -0.54% | ||
| 1 week | -0.54% | ||
| Current month | +0.27% | ||
| 1 month | -8.50% | ||
| 3 months | +27.53% | ||
| 6 months | +5.78% | ||
| Current year | -13.68% |
1 week
3.55
3.72
1 month
3.484.60
Current year
2.596.30
1 year
2.596.30
3 years
2.5910.14
5 years
2.5930.15
10 years
2.5930.15
| Director | Title | Age | Since |
|---|---|---|---|
Di Fan Shen
CEO | Chief Executive Officer | 46 | 2023-11-27 |
Yan Wu Tu
DFI | Director of Finance/CFO | 46 | 2019-08-31 |
Hiu Leong Tsui
SEC | Corporate Secretary | - | 2023-08-11 |
| Manager | Title | Age | Since |
|---|---|---|---|
Di Fan Shen
BRD | Director/Board Member | 46 | 2021-10-12 |
Yi Fei Huang
BRD | Director/Board Member | 51 | 2019-06-08 |
Shun Yan Zhu
CHM | Chairman | 53 | 2020-03-15 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.59% | 346 M€ | +16.87% | ||
| 1.56% | 108 M€ | +22.56% | - | |
| 1.56% | 16 M€ | +17.20% | - | |
| 1.42% | 0 M€ | 0.00% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| -0.54% | -0.54% | -15.47% | -47.11% | 7.6B | ||
| -0.86% | +3.78% | -21.28% | -53.28% | 11.93B | ||
| -0.33% | +2.52% | -56.95% | -80.77% | 7.74B | ||
| +4.79% | +7.60% | -9.76% | +55.38% | 5.84B | ||
| +0.59% | -0.15% | +35.33% | +35.54% | 5.25B | ||
| +1.34% | +4.33% | -11.45% | - | 4.12B | ||
| -1.92% | +2.49% | -26.59% | -11.23% | 3.9B | ||
| -1.17% | +5.74% | +20.81% | +8.05% | 3.29B | ||
| -1.91% | -1.62% | +39.38% | +103.71% | 3.15B | ||
| +1.49% | +3.97% | -21.92% | -49.10% | 2.7B | ||
| Average | +0.15% | +2.84% | -6.79% | -4.31% | 5.55B | |
| Weighted average by Cap. | +0.11% | +3.12% | -12.63% | -18.13% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 30.75B 32.85B 4.22B 4.02B 3.74B 3.33B 5.94B 358B 6.52B 46.5B 17.24B 147B 15.86B 15.5B 631B | 33.83B 36.14B 4.64B 4.42B 4.11B 3.67B 6.53B 393B 7.17B 51.16B 18.97B 161B 17.45B 17.06B 694B |
| Net income | 1.64B 1.76B 226M 215M 200M 178M 317M 19.11B 348M 2.49B 922M 7.84B 848M 829M 33.74B | 2.09B 2.23B 287M 273M 254M 227M 404M 24.32B 443M 3.16B 1.17B 9.97B 1.08B 1.05B 42.93B |
| Net Debt | -11.72B -12.52B -1.61B -1.53B -1.43B -1.27B -2.26B -136B -2.48B -17.72B -6.57B -55.89B -6.04B -5.91B -241B | -13.93B -14.88B -1.91B -1.82B -1.69B -1.51B -2.69B -162B -2.95B -21.07B -7.81B -66.42B -7.18B -7.02B -286B |
More financial data
* Estimated data
Employees
1,422
Sector
Drug Retailers
Calendar
2025-05-26
- Q4 2025 Earnings Release (Projected)
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-12-04 | 3.660 $ | -0.54% | 38,066,317 |
| 24-12-03 | 3.680 $ | +0.27% | 41,703,160 |
| 24-12-02 | 3.670 $ | +0.55% | 39,468,000 |
| 24-11-29 | 3.650 $ | +2.24% | 47,157,170 |
| 24-11-28 | 3.570 $ | -2.99% | 46,121,500 |
Delayed Quote Hong Kong S.E., December 04, 2024 at 03:08 am EST
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
3.445CNY
Average target price
4.468CNY
Spread / Average Target
+29.70%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 241 Stock